JP2019514877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514877A5 JP2019514877A5 JP2018555177A JP2018555177A JP2019514877A5 JP 2019514877 A5 JP2019514877 A5 JP 2019514877A5 JP 2018555177 A JP2018555177 A JP 2018555177A JP 2018555177 A JP2018555177 A JP 2018555177A JP 2019514877 A5 JP2019514877 A5 JP 2019514877A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound according
- linker
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 4
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 claims description 4
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 235000013877 carbamide Nutrition 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 150000003457 sulfones Chemical class 0.000 claims description 4
- 150000003568 thioethers Chemical class 0.000 claims description 4
- 102000015367 CRBN Human genes 0.000 claims description 2
- 101000941994 Homo sapiens Protein cereblon Proteins 0.000 claims description 2
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 claims description 2
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 claims description 2
- 230000002424 anti-apoptotic effect Effects 0.000 claims description 2
- 230000018883 protein targeting Effects 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims 2
- 0 *Nc(cc1)cc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O Chemical compound *Nc(cc1)cc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O 0.000 description 2
- BTODVRFBCGOZGM-UHFFFAOYSA-N CC(C)Nc(cccc1C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O Chemical compound CC(C)Nc(cccc1C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O BTODVRFBCGOZGM-UHFFFAOYSA-N 0.000 description 1
- AOAWMQJVACPFTA-UHFFFAOYSA-N CC(C)Nc(cccc1CN2C(CCC(N3)=O)C3=O)c1C2=O Chemical compound CC(C)Nc(cccc1CN2C(CCC(N3)=O)C3=O)c1C2=O AOAWMQJVACPFTA-UHFFFAOYSA-N 0.000 description 1
- KBKBMAPKDBDLGN-UHFFFAOYSA-N CC(C)Oc(cc1)cc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O Chemical compound CC(C)Oc(cc1)cc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O KBKBMAPKDBDLGN-UHFFFAOYSA-N 0.000 description 1
- SBEBGZQERFEASE-UHFFFAOYSA-N CCC(C)c(cc1C(N2C(CCC(N3)=O)C3=O)=O)ccc1C2=O Chemical compound CCC(C)c(cc1C(N2C(CCC(N3)=O)C3=O)=O)ccc1C2=O SBEBGZQERFEASE-UHFFFAOYSA-N 0.000 description 1
- FAZWECWNUTULOK-UHFFFAOYSA-N CCc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O Chemical compound CCc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O FAZWECWNUTULOK-UHFFFAOYSA-N 0.000 description 1
- GOTYRUGSSMKFNF-UHFFFAOYSA-N Nc1cccc2c1CN(C(CCC(N1)=O)C1=O)C2=O Chemical compound Nc1cccc2c1CN(C(CCC(N1)=O)C1=O)C2=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662325856P | 2016-04-21 | 2016-04-21 | |
| US62/325,856 | 2016-04-21 | ||
| PCT/US2017/028875 WO2017184995A1 (en) | 2016-04-21 | 2017-04-21 | Compounds that induce degradation of anti-apoptotic bcl-2 family proteins and the uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514877A JP2019514877A (ja) | 2019-06-06 |
| JP2019514877A5 true JP2019514877A5 (https=) | 2020-06-11 |
| JP6936498B2 JP6936498B2 (ja) | 2021-09-15 |
Family
ID=60116391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018555177A Active JP6936498B2 (ja) | 2016-04-21 | 2017-04-21 | 抗アポトーシス性Ｂｃｌ−２ファミリータンパク質の分解を誘導する化合物及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10807977B2 (https=) |
| EP (1) | EP3445452A4 (https=) |
| JP (1) | JP6936498B2 (https=) |
| KR (1) | KR102447884B1 (https=) |
| CN (1) | CN109152933B (https=) |
| AU (1) | AU2017254687B2 (https=) |
| WO (2) | WO2017184995A1 (https=) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3139942B1 (en) | 2014-05-05 | 2019-12-18 | Bioventures, Llc | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
| WO2016014625A1 (en) | 2014-07-22 | 2016-01-28 | Board Of Trustees Of The University Of Arkansas | Compositions and methods for selectively depleting senescent cells |
| CN109152933B (zh) * | 2016-04-21 | 2022-12-02 | 生物风险投资有限责任公司 | 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途 |
| CN110506039A (zh) | 2016-10-11 | 2019-11-26 | 阿尔维纳斯股份有限公司 | 用于雄激素受体靶向降解的化合物和方法 |
| MX2019005007A (es) | 2016-11-01 | 2019-07-18 | Arvinas Inc | Protac dirigidos a la proteína tau y métodos asociados de uso. |
| EP4467143B1 (en) | 2017-07-10 | 2026-03-11 | Celgene Corporation | Method for preparing 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3-fluorobenzonitrile |
| KR20200108301A (ko) | 2018-01-10 | 2020-09-17 | 리커리엄 아이피 홀딩스, 엘엘씨 | 벤즈아미드 화합물 |
| ES3041854T3 (en) * | 2018-01-22 | 2025-11-17 | Bioventures Llc | Bcl-2 proteins degraders for cancer treatment |
| US12539292B2 (en) | 2018-04-01 | 2026-02-03 | Arvinas Operations, Inc. | BRM targeting compounds and associated methods of use |
| US12084423B2 (en) | 2018-05-18 | 2024-09-10 | Bioventures, Llc | Piperlongumine analogues and uses thereof |
| WO2019218904A1 (zh) * | 2018-05-18 | 2019-11-21 | 四川科伦博泰生物医药股份有限公司 | 非天然氨基酸类衍生物、其制备方法及用途 |
| US11026963B2 (en) * | 2018-07-11 | 2021-06-08 | Rubedo Life Sciences, Inc. | Senolytic compositions and uses thereof |
| CN113660937A (zh) * | 2019-02-08 | 2021-11-16 | 佛罗里达大学研究基金公司 | 治疗剂和治疗方法 |
| AU2020310147A1 (en) * | 2019-07-10 | 2022-01-06 | Recurium Ip Holdings, Llc | Bcl-2 protein inhibitors |
| EP3999182A1 (en) * | 2019-07-17 | 2022-05-25 | Arvinas Operations, Inc. | Tau-protein targeting compounds and associated methods of use |
| JP7502425B2 (ja) * | 2019-10-01 | 2024-06-18 | アルヴィナス・オペレーションズ・インコーポレイテッド | Ｂｒｍ標的化化合物および関連使用方法 |
| CN112707900B (zh) * | 2019-10-24 | 2022-06-10 | 上海科技大学 | 蛋白降解剂及其在疾病治疗中的应用 |
| WO2021126973A1 (en) * | 2019-12-17 | 2021-06-24 | Orionis Biosciences, Inc. | Compounds modulating protein recruitment and/or degradation |
| US12441722B2 (en) | 2020-01-15 | 2025-10-14 | University Of Florida Research Foundation, Incorporated | Therapeutic agents and methods of treatment |
| US20230128137A1 (en) * | 2020-03-12 | 2023-04-27 | Medshine Discovery Inc. | Benzo five-membered cyclic compound |
| US20230167105A1 (en) * | 2020-04-28 | 2023-06-01 | Recurium Ip Holdings, Llc | Bcl-2 protein inhibitors |
| CR20220630A (es) | 2020-05-09 | 2023-01-23 | Arvinas Operations Inc | Métodos para fabricar un compuesto bifuncional, formas ultrapuras del compuesto bifuncional y formas de dosificación que comprenden el mismo |
| AU2022207648A1 (en) | 2021-01-13 | 2023-07-27 | Monte Rosa Therapeutics Ag | Isoindolinone compounds |
| JP2024505562A (ja) | 2021-02-02 | 2024-02-06 | レス ラボラトイレス セルビエル | 選択的ｂｃｌ－ｘｌ ｐｒｏｔａｃ化合物及び使用の方法 |
| KR20240020735A (ko) | 2021-05-07 | 2024-02-15 | 카이메라 쎄라퓨틱스 인코포레이티드 | Cdk2 분해제 및 그 용도 |
| WO2022255888A1 (en) * | 2021-06-01 | 2022-12-08 | Captor Therapeutics S.A. | Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target mcl-1 protein |
| JP2024534223A (ja) * | 2021-09-01 | 2024-09-18 | シーザン ハイスーク ファーマシューティカル カンパニー リミテッド | Ｂｃｌ－２ファミリータンパク質を分解する化合物及びその医薬的な応用 |
| US20250197387A1 (en) * | 2021-09-17 | 2025-06-19 | Kymera Therapeutics, Inc. | Bcl-xl degraders and uses thereof |
| US20250136593A1 (en) * | 2021-11-17 | 2025-05-01 | Hitgen Inc. | Degradation agent and use thereof |
| JP7825122B2 (ja) * | 2022-01-04 | 2026-03-06 | 上海科技大学 | Ｂｃｌ－２ファミリータンパク質リガンド化合物に基づいて開発したタンパク質分解剤及びそれらの応用 |
| WO2023205802A2 (en) * | 2022-04-22 | 2023-10-26 | Sens Research Foundation | Senolytic targets of senescent cells |
| WO2023215449A1 (en) | 2022-05-06 | 2023-11-09 | Treeline Biosciences, Inc. | Tetrahydroisoquinoline heterobifunctional bcl-xl degraders |
| EP4519259A1 (en) | 2022-05-06 | 2025-03-12 | Treeline Biosciences, Inc. | Tetrahydroisoquinoline heterobifunctional bcl-xl degraders |
| EP4519260A1 (en) | 2022-05-06 | 2025-03-12 | Treeline Biosciences, Inc. | Tetrahydroisoquinoline heterobifunctional bcl-xdegraders |
| TW202402272A (zh) * | 2022-07-12 | 2024-01-16 | 中國商正大天晴藥業集團股份有限公司 | 含有三氟甲基基團的化合物 |
| EP4565236A1 (en) * | 2022-08-02 | 2025-06-11 | Beijing Neox Biotech Limited | Bcl-xl degrading compounds |
| CN115141198A (zh) * | 2022-09-01 | 2022-10-04 | 上海睿跃生物科技有限公司 | 降解蛋白的化合物及其应用和药物 |
| WO2024051741A1 (zh) * | 2022-09-06 | 2024-03-14 | 西藏海思科制药有限公司 | 一种抑制Bcl-2或Bcl-xL的化合物及其在医药上的应用 |
| CN115260191B (zh) * | 2022-09-29 | 2022-12-27 | 上海睿跃生物科技有限公司 | 哌啶类化合物及其制备方法和应用 |
| CN115286689B (zh) * | 2022-09-29 | 2023-01-06 | 上海睿跃生物科技有限公司 | 靶向降解Bcl-2蛋白的化合物及其应用和药物 |
| TW202430522A (zh) * | 2022-09-30 | 2024-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 一種用於ｂｃｌ－２蛋白靶向降解的嵌合體化合物、其製備方法及其在醫藥上的應用 |
| CN115286630B (zh) * | 2022-10-09 | 2022-12-27 | 上海睿跃生物科技有限公司 | 哌嗪类化合物及其制备方法和应用 |
| WO2024078581A1 (en) * | 2022-10-12 | 2024-04-18 | Appicine Therapeutics (Hk) Limited | Selective bcl-xl protac compounds and uses thereof |
| KR20250130610A (ko) * | 2022-12-06 | 2025-09-02 | 캡터 테라퓨틱스 에스.에이. | 유비퀴틴 리가제 및 표적 mcl-1 단백질에 결합하는 이작용성 화합물을 사용하는 표적화된 단백질 분해 |
| WO2024123195A1 (en) * | 2022-12-06 | 2024-06-13 | Captor Therapeutics S.A. | Targeted protein degradation using prodrugs of bifunctional compounds that bind ubiquitin ligase and target mcl-1 protein |
| JP2026507476A (ja) * | 2023-02-17 | 2026-03-04 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | トリフルオロメタンスルホニル基を含む化合物 |
| EP4719408A1 (en) * | 2023-05-30 | 2026-04-08 | Ascentage Pharma (Suzhou) Co., Ltd. | Bcl-2/bcl-xl protein degrader and use thereof |
| WO2025101575A1 (en) | 2023-11-07 | 2025-05-15 | Treeline Biosciences, Inc. | Tetrahydroisoquinoline heterobifunctional bcl-x l degraders |
| TW202527930A (zh) | 2023-11-07 | 2025-07-16 | 美商樹線生物科學公司 | 四氫異喹啉異雙功能ｂｃｌ－ｘｌ降解劑 |
| TW202535872A (zh) | 2023-11-07 | 2025-09-16 | 美商樹線生物科學公司 | 四氫異喹啉異雙功能ｂｃｌ－ｘｌ降解劑 |
| WO2025117556A1 (en) * | 2023-11-27 | 2025-06-05 | Rubedo Life Sciences, Inc. | Phosphorous containing bcl inhibitors and senolytic compounds and uses thereof |
| TW202535392A (zh) | 2023-12-08 | 2025-09-16 | 美商亞文納營運公司 | 使用雄性素受體降解劑治療脊髓延髓性肌肉萎縮 |
| WO2025136208A1 (en) | 2023-12-21 | 2025-06-26 | Hadjab Saida | Senolytic compounds for use in the treatment and/or prevention of a headache disorder and/or chronic pain |
| CN117624134B (zh) * | 2024-01-26 | 2024-05-03 | 南昌市第一医院 | 一种靶向降解hdac4的化合物及其制备方法和应用 |
| CN118908940B (zh) * | 2024-10-11 | 2024-12-31 | 齐鲁理工学院 | 一种靶向抗凋亡Bcl-2的蛋白水解靶向嵌合体的制备和应用 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394448A (en) | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| US4529561A (en) | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
| US4241046A (en) | 1978-11-30 | 1980-12-23 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4925661A (en) | 1984-04-19 | 1990-05-15 | Leaf Huang | Target-specific cytotoxic liposomes |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US4755388A (en) | 1984-11-09 | 1988-07-05 | The Regents Of The University Of California | Liposome-encapsulated 5-fluoropyrimidines and methods for their use |
| DE3542773A1 (de) | 1985-12-04 | 1987-06-11 | Roehm Pharma Gmbh | Hautwirksame pharmaka mit liposomen als wirkstofftraeger |
| US4828837A (en) | 1987-03-30 | 1989-05-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition, its production and application |
| US5077211A (en) | 1988-07-06 | 1991-12-31 | Applied Genetics, Inc. | Purification and administration of dna repair enzymes |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5043164A (en) | 1989-01-17 | 1991-08-27 | The University Of Tennessee Research Corporation | Blood-stable, cholesterol-free liposomes |
| US5064655A (en) | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5270339A (en) | 1991-04-05 | 1993-12-14 | Kanagafuchi Kagaku Kogyo Kabushiki Kaisha | Phenoxybenzene derivative |
| US5491069A (en) | 1994-02-18 | 1996-02-13 | The Regents Of The University Of California | Biomarkers of cell senescence |
| US5888764A (en) | 1995-01-20 | 1999-03-30 | Uab Research Foundation | Human fas gene promoter region |
| DE19713393C2 (de) | 1997-04-01 | 2002-12-05 | Apotech Res & Dev Ltd | Flip-Gen und Flip-Protein |
| JPH11349568A (ja) | 1998-06-08 | 1999-12-21 | Maruho Co Ltd | ラクタム誘導体及びその医薬用途 |
| CA2338328A1 (en) | 1998-07-21 | 2000-02-03 | Thomas Jefferson University | Small molecule inhibitors of bcl-2 proteins |
| AUPR038200A0 (en) | 2000-09-26 | 2000-10-19 | Beta Peptide Foundation Pty Ltd, The | Compositions and methods for delaying, preventing, rejuvenating or reversing senescence |
| WO2002097053A2 (en) | 2001-05-30 | 2002-12-05 | The Regents Of The University Of Michigan | Small molecule antagonists of bcl2 family proteins |
| ES2276895T3 (es) | 2002-05-07 | 2007-07-01 | Institut Pasteur | Cribado de peptidos qque inhiben la union de pp1c a las proteinas bcl-2, bcl-xi y bcl-w. |
| AU2003245436A1 (en) | 2003-01-23 | 2004-08-23 | The Trustees Of Columbia University In The City Of New York | Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof |
| ES2382377T3 (es) | 2003-05-30 | 2012-06-07 | Gemin X Pharmaceuticals Canada Inc. | Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer |
| US20050208151A1 (en) | 2003-10-30 | 2005-09-22 | Entelos, Inc. | Treatment of rheumatoid arthritis with FLIP antagonists |
| US7973161B2 (en) | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| JP2007525661A (ja) | 2003-12-12 | 2007-09-06 | セントルイス ユニバーシティー | 大分子その他の分析物の検出用生物センサー |
| RU2361872C2 (ru) | 2004-05-26 | 2009-07-20 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Циннамидное соединение |
| AU2005277223C1 (en) | 2004-08-20 | 2009-05-21 | The Regents Of The University Of Michigan | Small molecule inhibitors of anti-apoptotic Bcl-2 family members and the uses thereof |
| PL1888550T3 (pl) | 2005-05-12 | 2014-12-31 | Abbvie Bahamas Ltd | Promotory apoptozy |
| EP2135078B1 (en) | 2007-03-09 | 2013-08-21 | DiscoveRx Corporation | Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| EA200901212A1 (ru) | 2007-03-29 | 2010-04-30 | Новартис Аг | 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний |
| US20100310504A1 (en) | 2007-09-26 | 2010-12-09 | Lowe Scott W | Methods for treating fibrosis by modulating cellular senescence |
| US8039668B2 (en) | 2008-10-17 | 2011-10-18 | Burnham Institute For Medical Research | Naphthalene-based inhibitors of anti-apoptotic proteins |
| WO2009085216A2 (en) | 2007-12-20 | 2009-07-09 | Squicor | Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease |
| US20090312373A1 (en) | 2008-03-11 | 2009-12-17 | The General Hospital Corporation | Methods for the treatment of cancer using piperlongumine and piperlongumine analogs |
| US8168784B2 (en) | 2008-06-20 | 2012-05-01 | Abbott Laboratories | Processes to make apoptosis promoters |
| US20100086941A1 (en) | 2008-10-01 | 2010-04-08 | Adami Guy R | Methods for determining aged based accumulation of senescent cells using senescence specific DNA damage markers |
| NZ593536A (en) | 2008-12-19 | 2013-07-26 | Genentech Inc | Quinoline derivatives and methods of use |
| WO2010080503A1 (en) | 2008-12-19 | 2010-07-15 | Genentech, Inc. | Heterocyclic compounds and methods of use |
| WO2010138588A2 (en) | 2009-05-26 | 2010-12-02 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| EP2289528A1 (en) | 2009-07-21 | 2011-03-02 | DSM IP Assets B.V. | Novel nutraceutical compositions containing black pepper or its constituents improving mental performance |
| US8349832B2 (en) | 2009-09-02 | 2013-01-08 | Canthera Therapeutics | Compounds and compositions for treating cancer |
| US8318737B2 (en) | 2009-09-02 | 2012-11-27 | Canthera Therapeutics Inc. | Compounds and compositions for treating cancer |
| US20120157455A1 (en) | 2009-09-02 | 2012-06-21 | Canthera Therapeutics, Inc. | Compounds And Compositions For Treating Cancer |
| EP2519260A2 (en) | 2009-12-31 | 2012-11-07 | Deutsches Krebsforschungszentrum | Novel modulators of trail signalling |
| CN101774875A (zh) | 2010-01-08 | 2010-07-14 | 北京欧凯纳斯科技有限公司 | 一种荜拔酰胺类化合物的合成方法 |
| CN102125552A (zh) | 2010-01-20 | 2011-07-20 | 李绍路 | 荜茇酰胺衍生物在制备治疗癌症的药物中的用途及其药物组合物 |
| CN102146054A (zh) | 2010-02-10 | 2011-08-10 | 新昌县来益科技开发有限公司 | 荜茇酰胺衍生物及其药物组合物和在制备抑制肿瘤生长的药物中的用途 |
| WO2011130395A1 (en) | 2010-04-13 | 2011-10-20 | University Of Utah Research Foundation | Inhibitors of flip to treat cancer |
| ES2603129T3 (es) | 2010-11-23 | 2017-02-23 | Abbvie Ireland Unlimited Company | Métodos de tratamiento utilizando inhibidores selectivos de Bcl-2 |
| EP2668180B1 (en) * | 2011-01-25 | 2018-08-01 | The Regents of The University of Michigan | Bcl-2/bcl-xl inhibitors for use in the treatment of cancer |
| US8940737B2 (en) | 2011-10-14 | 2015-01-27 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| EP2602330A1 (en) | 2011-12-07 | 2013-06-12 | Palacky University, Olomouc | Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors and overcoming their resistance |
| KR102668696B1 (ko) * | 2012-01-12 | 2024-05-29 | 예일 유니버시티 | E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법 |
| US9828344B2 (en) | 2012-06-01 | 2017-11-28 | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) | Inhibitors of the notch signaling pathway and secretion for use in medicine |
| US9108923B2 (en) | 2012-07-20 | 2015-08-18 | Howard Hughes Medical Institute | Compounds, compositions, and methods for cancer therapy |
| CN103601670B (zh) | 2012-11-20 | 2016-06-15 | 中国人民解放军第二军医大学 | 荜拔酰胺类似物及其制备方法与应用 |
| WO2014089124A1 (en) | 2012-12-03 | 2014-06-12 | Cenexys, Inc. | Immunogenic compositions for inducing an immune response for elimination of senescent cells |
| GB201311910D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel Compounds |
| EP3689886A1 (en) * | 2013-01-16 | 2020-08-05 | The Regents of The University of Michigan | Bcl-2/bcl-xl inhibitors and their use in the treatment of cancer |
| RU2015149680A (ru) | 2013-04-21 | 2017-05-24 | Йеда Ресеарч Энд Девелопмент Ко. Лтд. | Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w |
| IL286427B2 (en) | 2014-01-28 | 2024-08-01 | Mayo Found Medical Education & Res | Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease |
| RU2738833C9 (ru) | 2014-04-14 | 2022-02-28 | Арвинас, Оперэйшнз, Инк. | Имидные модуляторы протеолиза и способы их применения |
| EP3139942B1 (en) | 2014-05-05 | 2019-12-18 | Bioventures, Llc | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
| WO2016014625A1 (en) | 2014-07-22 | 2016-01-28 | Board Of Trustees Of The University Of Arkansas | Compositions and methods for selectively depleting senescent cells |
| US10071164B2 (en) | 2014-08-11 | 2018-09-11 | Yale University | Estrogen-related receptor alpha based protac compounds and associated methods of use |
| US9694084B2 (en) | 2014-12-23 | 2017-07-04 | Dana-Farber Cancer Institute, Inc. | Methods to induce targeted protein degradation through bifunctional molecules |
| WO2016118859A1 (en) | 2015-01-22 | 2016-07-28 | Board Of Trustees Of The University Of Arkansas | Compositions and methods for selectively depleting senescent cells comprising flip |
| WO2016118855A1 (en) | 2015-01-22 | 2016-07-28 | Board Of Trustees Of The University Of Arkansas | Compositions and methods for selectively depleting senescent cells comprising death receptors |
| US20180000816A1 (en) * | 2015-02-06 | 2018-01-04 | Unity Biotechnology, Inc. | Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions |
| EP3270917A4 (en) * | 2015-03-18 | 2018-08-08 | Arvinas, Inc. | Compounds and methods for the enhanced degradation of targeted proteins |
| CN105085620B (zh) | 2015-06-25 | 2018-05-08 | 中山大学附属第一医院 | 一种靶向泛素化降解Smad3的化合物 |
| AU2016295984B2 (en) | 2015-07-21 | 2021-05-27 | Fundació Investigació Hospital General Universitari De València Per A La Investigació Biomèdica I Ciències De La Salut | Combination comprising pterostilbene for the treatment of cancer |
| US10772962B2 (en) * | 2015-08-19 | 2020-09-15 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of bromodomain-containing proteins |
| WO2017101851A1 (en) | 2015-12-18 | 2017-06-22 | Unity Biotechnology, Inc. | Acylsulfonamide derivatives for treating senescence-associated diseases and disorders |
| CN109152933B (zh) | 2016-04-21 | 2022-12-02 | 生物风险投资有限责任公司 | 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途 |
| US20190054097A1 (en) | 2016-04-21 | 2019-02-21 | Bioventures, Llc | Compositions targeting senescent cells and the uses thereof |
| ES3041854T3 (en) * | 2018-01-22 | 2025-11-17 | Bioventures Llc | Bcl-2 proteins degraders for cancer treatment |
-
2017
- 2017-04-21 CN CN201780024822.5A patent/CN109152933B/zh active Active
- 2017-04-21 WO PCT/US2017/028875 patent/WO2017184995A1/en not_active Ceased
- 2017-04-21 AU AU2017254687A patent/AU2017254687B2/en active Active
- 2017-04-21 EP EP17786729.8A patent/EP3445452A4/en active Pending
- 2017-04-21 US US16/095,260 patent/US10807977B2/en active Active
- 2017-04-21 JP JP2018555177A patent/JP6936498B2/ja active Active
- 2017-04-21 KR KR1020187029999A patent/KR102447884B1/ko active Active
-
2019
- 2019-10-17 WO PCT/US2019/056837 patent/WO2020081880A1/en not_active Ceased
-
2020
- 2020-07-03 US US16/920,649 patent/US11319316B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019514877A5 (https=) | ||
| JP2022547716A5 (https=) | ||
| JP2015518831A5 (https=) | ||
| RU2016134258A (ru) | Конъюгат лекарственного средства с направляющей молекулой и двумя различными лекарственными средствами | |
| EP4241847C0 (en) | ENHANCED CELL TARGETING BINDING MOLECULE | |
| CY1124728T1 (el) | Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων | |
| EP3717505A4 (en) | GENENICALLY MODIFIED DNA-BINDING PROTEINS | |
| JP2011057678A5 (https=) | ||
| EP3821011A4 (en) | TRANSPOSOME-ACTIVATED DNA/RNA SEQUENCING (TED RNA-SEQ) | |
| CY1118442T1 (el) | Μεθοδοι αγωγης δια της χρησεως εκλεκτικων αναστολεων bcl-2 | |
| LT3571224T (lt) | Patobulintos serumo albumino rišamosios medžiagos | |
| CY1117929T1 (el) | Παραγωγα σουλφοναμιδιου ως bcl-2-εκλεκτικοι παραγοντες διεγερσης αποπτωσης για τη θεραπεια καρκινου και ανοσοασθενειων | |
| JP2019524645A5 (https=) | ||
| IL255125A0 (en) | Evaluation of cas9 molecule/guide rna molecule complexs | |
| EP2560476A4 (en) | COMBINATIONS WITH CRY34AB / 35AB AND CRY3AA PROTEINS TO PREVENT THE DEVELOPMENT OF RESISTANCE IN CORAL ROOT DRILLS (DIABROTICA SPP.) | |
| JP2013047244A5 (https=) | ||
| JP2013512915A5 (https=) | ||
| EP3917542A4 (en) | MULTISPECIFIC BINDING PROTEINS | |
| EP3729090A4 (en) | MODIFIED BIOTIN-BINDING PROTEINS FOR IMMOBILIZATION | |
| EP3816290A4 (en) | ANTIBODY BINDING TO THE CELL ADHESION MOLECULE 3 | |
| JP2010520851A5 (https=) | ||
| EP3914608A4 (en) | NOVEL INSECT CONTROL PROTEINS | |
| IL309025B1 (en) | Deaminase-based rna sensors | |
| EP3708667A4 (en) | IMMUNOGLOBULIN BINDING PROTEINS | |
| EP3849562A4 (en) | COMBINATION COMPOSITIONS WITH A BETA-LACTAMASE INHIBITOR |